APA (7th ed.) Citation

Liu, D., Huang, Y., Chen, B., Zeng, J., Guo, N., Zhang, S., . . . Li, W. (2011). Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma. Cancer, 117(16), 3763-3773. https://doi.org/10.1002/cncr.25959

Chicago Style (17th ed.) Citation

Liu, Dan, et al. "Activation of Mammalian Target of Rapamycin Pathway Confers Adverse Outcome in Nonsmall Cell Lung Carcinoma." Cancer 117, no. 16 (2011): 3763-3773. https://doi.org/10.1002/cncr.25959.

MLA (9th ed.) Citation

Liu, Dan, et al. "Activation of Mammalian Target of Rapamycin Pathway Confers Adverse Outcome in Nonsmall Cell Lung Carcinoma." Cancer, vol. 117, no. 16, 2011, pp. 3763-3773, https://doi.org/10.1002/cncr.25959.